Skip to content

Author

Diana Valishayeva

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Genomic profiling–guided evaluation of metabolic correction with tirzepatide in patients with HFpEF: results from a prospective controlled study in Kazakhstan

The dual GIP/GLP-1 receptor agonist tirzepatide has demonstrated significant metabolic and cardiometabolic benefits in patients with heart failure with preserved ejection fraction (HFpEF). However, molecular mechanisms underlying its cardiovascular effects and determinants of individual therapeutic response remai...

A. Akilzhanova, D. Samatkyzy, D. Valishayeva et al. · 0 citations
Review Open access Sep 2026

Plant-Derived Dipeptidyl Peptidase-4 Inhibitors in Cardiometabolic Disorders: A Critical Review of Natural Scaffolds and Experimental Evidence

The evidence does not support using plant-derived DPP-4 inhibitors as substitutes for approved antidiabetic drugs and their greatest value lies in expanding chemical space and providing lead-like scaffolds for standardized potency, selectivity, kinetic and preclinical validation.

K. Zhapar, D. Samatkyzy, D. Valishayeva et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.